U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C16H14O2
Molecular Weight 238.2812
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of BENZYL CINNAMATE

SMILES

O=C(OCC1=CC=CC=C1)\C=C\C2=CC=CC=C2

InChI

InChIKey=NGHOLYJTSCBCGC-VAWYXSNFSA-N
InChI=1S/C16H14O2/c17-16(12-11-14-7-3-1-4-8-14)18-13-15-9-5-2-6-10-15/h1-12H,13H2/b12-11+

HIDE SMILES / InChI
Benzyl cinnamate (also known as Jacobson's solution) was used to treat chronic salpingitis, and in combination with vitamin A to treat cerebrovascular lesions. In addition, it is used in heavy oriental perfumes and as a fixative and as a flavoring agent.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Doses

Doses

DosePopulationAdverse events​
8 % single, topical
Highest studied dose
Dose: 8 %
Route: topical
Route: single
Dose: 8 %
Sources:
healthy, ADULT
Health Status: healthy
Age Group: ADULT
Sex: M+F
Food Status: UNKNOWN
Sources:
Other AEs: Irritation skin...
1 mL 1 times / day multiple, intramuscular
Highest studied dose
Dose: 1 mL, 1 times / day
Route: intramuscular
Route: multiple
Dose: 1 mL, 1 times / day
Sources:
unhealthy, ADULT
Health Status: unhealthy
Age Group: ADULT
Sex: F
Food Status: UNKNOWN
Sources:
AEs

AEs

AESignificanceDosePopulation
Irritation skin 3.2%
8 % single, topical
Highest studied dose
Dose: 8 %
Route: topical
Route: single
Dose: 8 %
Sources:
healthy, ADULT
Health Status: healthy
Age Group: ADULT
Sex: M+F
Food Status: UNKNOWN
Sources:
PubMed

PubMed

TitleDatePubMed
Benzyl cinnamate (Jacobson's solution) with vitamin A. A one-year experience in the treatment of cerebrovascular lesions.
1960-03
Cerebrovascular accidents; a clinical evaluation of treatment with a solution of benzyl cinnamate (Jacobson's solution) with vitamin A.
1958-12
Vascular changes in diabetic and arteriolosclerotic retinopathy obtained by a modified solution of benzyl cinnamate.
1953-04-15
Mode of action of benzyl cinnamate solution in chronic inflammatory lesions of the pelvis.
1951-08
Patents

Patents

Sample Use Guides

Unknown
Route of Administration: Other
In Vitro Use Guide
Unknown
Name Type Language
FEMA NO. 2142
Preferred Name English
BENZYL CINNAMATE
FCC   FHFI   HSDB   INCI   MART.   MI   WHO-DD  
INCI  
Official Name English
BENZYL TRANS-CINNAMATE
Systematic Name English
2-PROPENOIC ACID, 3-PHENYL-, PHENYLMETHYL ESTER
Common Name English
BENZYL 3-PHENYLPROPENOATE
Systematic Name English
BENZYL CINNAMATE [HSDB]
Common Name English
BENZYL CINNAMATE [FHFI]
Common Name English
2-PROPENOIC ACID, 3-PHENYL-, PHENYLMETHYL ESTER, (2E)-
Systematic Name English
BENZYL .GAMMA.-PHENYLACRYLATE
Common Name English
BENZYL CINNAMATE [FCC]
Common Name English
BENZYL CINNAMATE [MART.]
Common Name English
NSC-11780
Code English
NSC-44403
Code English
3-PHENYL-2-PROPENOIC ACID BENZYL ESTER
Systematic Name English
CINNAMIC ACID, BENZYL ESTER
Common Name English
BENZYL CINNAMATE [MI]
Common Name English
BENZYL CINNAMATE, (E)-
Systematic Name English
CINNAMEIN
Common Name English
Benzyl cinnamate [WHO-DD]
Common Name English
Classification Tree Code System Code
EC SCIENTIFIC COMMITTEE ON CONSUMER SAFETY OPINION SCCS/1459/11
Created by admin on Mon Mar 31 17:55:31 GMT 2025 , Edited by admin on Mon Mar 31 17:55:31 GMT 2025
JECFA EVALUATION BENZYL CINNAMATE
Created by admin on Mon Mar 31 17:55:31 GMT 2025 , Edited by admin on Mon Mar 31 17:55:31 GMT 2025
CFR 21 CFR 172.515
Created by admin on Mon Mar 31 17:55:31 GMT 2025 , Edited by admin on Mon Mar 31 17:55:31 GMT 2025
Code System Code Type Description
EVMPD
SUB13024MIG
Created by admin on Mon Mar 31 17:55:31 GMT 2025 , Edited by admin on Mon Mar 31 17:55:31 GMT 2025
PRIMARY
DAILYMED
V67O3RO97U
Created by admin on Mon Mar 31 17:55:31 GMT 2025 , Edited by admin on Mon Mar 31 17:55:31 GMT 2025
PRIMARY
EPA CompTox
DTXSID3041663
Created by admin on Mon Mar 31 17:55:31 GMT 2025 , Edited by admin on Mon Mar 31 17:55:31 GMT 2025
PRIMARY
JECFA MONOGRAPH
557
Created by admin on Mon Mar 31 17:55:31 GMT 2025 , Edited by admin on Mon Mar 31 17:55:31 GMT 2025
PRIMARY
NSC
11780
Created by admin on Mon Mar 31 17:55:31 GMT 2025 , Edited by admin on Mon Mar 31 17:55:31 GMT 2025
PRIMARY
RXCUI
1649557
Created by admin on Mon Mar 31 17:55:31 GMT 2025 , Edited by admin on Mon Mar 31 17:55:31 GMT 2025
PRIMARY RxNorm
CAS
103-41-3
Created by admin on Mon Mar 31 17:55:31 GMT 2025 , Edited by admin on Mon Mar 31 17:55:31 GMT 2025
PRIMARY
NSC
44403
Created by admin on Mon Mar 31 17:55:31 GMT 2025 , Edited by admin on Mon Mar 31 17:55:31 GMT 2025
PRIMARY
SMS_ID
100000087378
Created by admin on Mon Mar 31 17:55:31 GMT 2025 , Edited by admin on Mon Mar 31 17:55:31 GMT 2025
PRIMARY
ECHA (EC/EINECS)
203-109-3
Created by admin on Mon Mar 31 17:55:31 GMT 2025 , Edited by admin on Mon Mar 31 17:55:31 GMT 2025
PRIMARY
WIKIPEDIA
Benzyl cinnamate
Created by admin on Mon Mar 31 17:55:31 GMT 2025 , Edited by admin on Mon Mar 31 17:55:31 GMT 2025
PRIMARY
MERCK INDEX
m2403
Created by admin on Mon Mar 31 17:55:31 GMT 2025 , Edited by admin on Mon Mar 31 17:55:31 GMT 2025
PRIMARY Merck Index
FDA UNII
V67O3RO97U
Created by admin on Mon Mar 31 17:55:31 GMT 2025 , Edited by admin on Mon Mar 31 17:55:31 GMT 2025
PRIMARY
MESH
C526327
Created by admin on Mon Mar 31 17:55:31 GMT 2025 , Edited by admin on Mon Mar 31 17:55:31 GMT 2025
PRIMARY
HSDB
359
Created by admin on Mon Mar 31 17:55:31 GMT 2025 , Edited by admin on Mon Mar 31 17:55:31 GMT 2025
PRIMARY
PUBCHEM
5273469
Created by admin on Mon Mar 31 17:55:31 GMT 2025 , Edited by admin on Mon Mar 31 17:55:31 GMT 2025
PRIMARY
CAS
78277-23-3
Created by admin on Mon Mar 31 17:55:31 GMT 2025 , Edited by admin on Mon Mar 31 17:55:31 GMT 2025
ALTERNATIVE